Sign up
Log in
12 Health Care Stocks Moving In Wednesday's Intraday Session
Share
Listen to the news

Gainers

  • CervoMed (NASDAQ:CRVO) stock increased by 151.1% to $5.93 during Wednesday's regular session. The market value of their outstanding shares is at $48.9 million.
  • OptimizeRx (NASDAQ:OPRX) shares rose 35.74% to $5.62. The company's market cap stands at $103.5 million. As per the press release, Q4 earnings came out today.
  • Healthcare Triangle (NASDAQ:HCTI) shares increased by 26.86% to $0.41. The market value of their outstanding shares is at $2.6 million.
  • HeartSciences (NASDAQ:HSCS) stock increased by 19.86% to $3.5. The market value of their outstanding shares is at $3.4 million.
  • Baird Medical Investment (NASDAQ:BDMD) stock rose 18.18% to $5.46. The market value of their outstanding shares is at $198.5 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 18.18% to $0.5. The market value of their outstanding shares is at $2.0 million.

Losers

  • Zynex (NASDAQ:ZYXI) stock fell 53.9% to $3.23 during Wednesday's regular session. The market value of their outstanding shares is at $102.8 million. As per the news, the Q4 earnings report came out yesterday.
  • Hepion Pharmaceuticals (NASDAQ:HEPA) shares decreased by 40.6% to $0.05.
  • Syros Pharmaceuticals (NASDAQ:SYRS) stock decreased by 30.23% to $0.09. The company's market cap stands at $2.5 million.
  • Impact BioMedical (AMEX:IBO) stock declined by 29.42% to $0.6. The company's market cap stands at $6.9 million.
  • Tenon Medical (NASDAQ:TNON) shares fell 25.24% to $1.13. The market value of their outstanding shares is at $3.5 million.
  • Cutera (NASDAQ:CUTR) shares declined by 18.54% to $0.09. The market value of their outstanding shares is at $1.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.